Biotech Hub

Lower courts have split on whether the federal government has the authority to issue such rules and whether they can take effect while the cases are argued.

When Californians go to the polls later this year, they will confront contentious healthcare choices. Voters will weigh whether to overturn a state law that bans flavored tobacco products and will…

Devices & Diagnostics, BioPharma In 2021 biotech had a median deal of $10 million and an average deal of $36.9 million, according to the report by PitchBook Data. Comparatively, medtech locked in an median of $3.9 million and $12.6 million average. https://medcitynews.com/author/ebardin

Child and adolescent mental health, palliative care and clinical AI are among opportunities that investors should consider closely this year an in the future.

The Supreme Court began hearing arguments Friday on major Biden administration work rules to bump up the nation’s vaccination rate against Covid-19 at a time of spiking coronavirus cases because of…

Many health care and ICU workers feel something more than being pushed beyond their limits as individuals. Many feel their profession is on fire and the world is silently watching.

Binah.ia has made its contactless, video-based blood pressure measurement technology commercially available to businesses.

‘Some came from mixing politics with positions of faith, which I think when it comes to vaccines has been pretty unfortunate,” said former NIH Director Francis Collins.

More than 65 institutional investors are urging the directors of companies making Covid-19 vaccines to tie executive compensation to vaccine equity.

Doctors have an arsenal of Covid-19 treatments, but setbacks and shortages are undercutting the options.